The board, which is chaired by Edward Holland, MD, who was recently hired as Aurion Biotech's top medical adviser, will engage with the company's management team in clinical development.
“The doctors on this board are among the best in our field,” said Dr. Holland.
“Their expertise, commitment to, and enthusiasm for Aurion Biotech’s cell therapy speak volumes about the transformational potential of this treatment to cure blindness resulting from corneal endothelial disease. I welcome their contributions. It’s a privilege to work closely with each of them.”
I’ve had the good fortune to catalyze innovations in ophthalmology for many years, and I’m confident that Aurion Biotech has all the key ingredients for success,” said Richard Lindstrom, MD, Aurion Biotech board member and medical advisor, and founder and attending surgeon of Minnesota Eye Consultants.
In addition to Dr. Holland and Dr. Lindstrom, the following physicians have been named to Aurion Biotech’s medical advisory board:
“We are extremely fortunate, not only because our medical advisors are some of the most talented corneal specialists in ophthalmology, but they are also deeply involved in the work we are doing,” said Greg Kunst, chief executive officer of Aurion Biotech.